502 related articles for article (PubMed ID: 26871948)
1. Improving the clinical impact of biomaterials in cancer immunotherapy.
Gammon JM; Dold NM; Jewell CM
Oncotarget; 2016 Mar; 7(13):15421-43. PubMed ID: 26871948
[TBL] [Abstract][Full Text] [Related]
2. Surgery-free injectable macroscale biomaterials for local cancer immunotherapy.
Lei K; Tang L
Biomater Sci; 2019 Feb; 7(3):733-749. PubMed ID: 30637428
[TBL] [Abstract][Full Text] [Related]
3. Immunoengineering with biomaterials for enhanced cancer immunotherapy.
Xie YQ; Wei L; Tang L
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2018 Jul; 10(4):e1506. PubMed ID: 29333729
[TBL] [Abstract][Full Text] [Related]
4. Advances in immunotherapy delivery from implantable and injectable biomaterials.
Leach DG; Young S; Hartgerink JD
Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
[TBL] [Abstract][Full Text] [Related]
5. Harnessing Biomaterials to Study and Direct Antigen-Specific Immunotherapy.
Edwards C; Carey ST; Jewell CM
ACS Appl Bio Mater; 2023 Jun; 6(6):2017-2028. PubMed ID: 37068126
[TBL] [Abstract][Full Text] [Related]
6. Cancer immunotherapy: accomplishments to date and future promise.
Helmy KY; Patel SA; Nahas GR; Rameshwar P
Ther Deliv; 2013 Oct; 4(10):1307-20. PubMed ID: 24116914
[TBL] [Abstract][Full Text] [Related]
7. The era of bioengineering: how will this affect the next generation of cancer immunotherapy?
Graciotti M; Berti C; Klok HA; Kandalaft L
J Transl Med; 2017 Jun; 15(1):142. PubMed ID: 28629381
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
[TBL] [Abstract][Full Text] [Related]
9. Self-Assembly as a Molecular Strategy to Improve Immunotherapy.
Froimchuk E; Carey ST; Edwards C; Jewell CM
Acc Chem Res; 2020 Nov; 53(11):2534-2545. PubMed ID: 33074649
[TBL] [Abstract][Full Text] [Related]
10. Cancer Nanomedicine: Lessons for Immuno-Oncology.
Sengupta S
Trends Cancer; 2017 Aug; 3(8):551-560. PubMed ID: 28780932
[TBL] [Abstract][Full Text] [Related]
11. Nanotechnology and Immunotherapy in Ovarian Cancer: Tracing New Landscapes.
Corradetti B; Pisano S; Conlan RS; Ferrari M
J Pharmacol Exp Ther; 2019 Sep; 370(3):636-646. PubMed ID: 30737357
[TBL] [Abstract][Full Text] [Related]
12. Emerging nanotechnologies for cancer immunotherapy.
Shukla S; Steinmetz NF
Exp Biol Med (Maywood); 2016 May; 241(10):1116-26. PubMed ID: 27190253
[TBL] [Abstract][Full Text] [Related]
13. Delivery strategies of cancer immunotherapy: recent advances and future perspectives.
Zhao Z; Zheng L; Chen W; Weng W; Song J; Ji J
J Hematol Oncol; 2019 Nov; 12(1):126. PubMed ID: 31779642
[TBL] [Abstract][Full Text] [Related]
14. Biomaterials-Mediated Engineering of the Immune System.
Backlund C; Jalili-Firoozinezhad S; Kim B; Irvine DJ
Annu Rev Immunol; 2023 Apr; 41():153-179. PubMed ID: 36696570
[TBL] [Abstract][Full Text] [Related]
15. Addressing barriers to effective cancer immunotherapy with nanotechnology: achievements, challenges, and roadmap to the next generation of nanoimmunotherapeutics.
Hong E; Dobrovolskaia MA
Adv Drug Deliv Rev; 2019 Feb; 141():3-22. PubMed ID: 29339144
[TBL] [Abstract][Full Text] [Related]
16. Improving Cancer Immunotherapy Outcomes Using Biomaterials.
Yan S; Luo Z; Li Z; Wang Y; Tao J; Gong C; Liu X
Angew Chem Int Ed Engl; 2020 Sep; 59(40):17332-17343. PubMed ID: 32297434
[TBL] [Abstract][Full Text] [Related]
17. Improving Vaccine and Immunotherapy Design Using Biomaterials.
Bookstaver ML; Tsai SJ; Bromberg JS; Jewell CM
Trends Immunol; 2018 Feb; 39(2):135-150. PubMed ID: 29249461
[TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy: harnessing the immune system to battle cancer.
Yang Y
J Clin Invest; 2015 Sep; 125(9):3335-7. PubMed ID: 26325031
[TBL] [Abstract][Full Text] [Related]
19. Delivering safer immunotherapies for cancer.
Milling L; Zhang Y; Irvine DJ
Adv Drug Deliv Rev; 2017 May; 114():79-101. PubMed ID: 28545888
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine and cancer immunotherapy - targeting immunosuppressive cells.
Torres Andón F; Alonso MJ
J Drug Target; 2015; 23(7-8):656-71. PubMed ID: 26453162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
